Status:
COMPLETED
Seasonal Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine in Children in Mali
Lead Sponsor:
University of Bamako
Collaborating Sponsors:
World Health Organization
Conditions:
Malaria
Eligibility:
All Genders
6-10 years
Phase:
NA
Brief Summary
Recent, randomized controlled trials conducted in areas of perennial malaria transmission have shown that intermittent preventive treatment (IPT) given at the time of vaccination reduced the incidence...
Eligibility Criteria
Inclusion
- Age 6 months to 10 years
- Agree to seek initial medical care for all medical illness in the study clinic during the study period
- Written informed consent by a parent or legal garden,
- No plan to travel for a long time during the study period.
Exclusion
- History of allergy to sulfa drugs or Sulfadoxine-pyrimethamine
- Chronic illness or symptomatic malaria at the time of enrollment
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2004
Estimated Enrollment :
262 Patients enrolled
Trial Details
Trial ID
NCT00623155
Start Date
July 1 2002
End Date
January 1 2004
Last Update
February 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Malaria Research and Training Center, Faculty of Medicine Pharmacy and Dentistry, University of Bamako
Bamako, Mali